Human Adiponectin (ACRP30) AssayLite™ Antibody (FITC Conjugate)
705.00 €
In Stock
quantity
product details
Catalog number: 88 - 10361-05041
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 150 ug
Z102595
Recombinant Human Adiponectin (Acrp30)
Adiponectin is an adipose-derived secreted protein that influences the body’s response to insulin. Adiponectin belongs to the soluble defence collagen super family and is involved with the promotion of adipocyte differentiation, fatty acid catabolism, and insulin resistance. Recombinant adiponectin is a multimeric glycoprotein that also has anti-inflammatory effects on the cell lining of blood vessel walls. High blood levels of adiponectin are associated with reduced risks of heart attacks while low levels are associated with obesity and an increased risk of heart attacks.
378.50 €
Z102597
Recombinant Human Adiponectin (Acrp30)
Adiponectin is an adipose-derived secreted protein that influences the body’s response to insulin. Adiponectin belongs to the soluble defence collagen super family and is involved with the promotion of adipocyte differentiation, fatty acid catabolism, and insulin resistance. Recombinant adiponectin is a multimeric glycoprotein that also has anti-inflammatory effects on the cell lining of blood vessel walls. High blood levels of adiponectin are associated with reduced risks of heart attacks while low levels are associated with obesity and an increased risk of heart attacks.
926.00 €
Z102599
Recombinant Human Adiponectin (Acrp30)
Adiponectin is an adipose-derived secreted protein that influences the body’s response to insulin. Adiponectin belongs to the soluble defence collagen super family and is involved with the promotion of adipocyte differentiation, fatty acid catabolism, and insulin resistance. Recombinant adiponectin is a multimeric glycoprotein that also has anti-inflammatory effects on the cell lining of blood vessel walls. High blood levels of adiponectin are associated with reduced risks of heart attacks while low levels are associated with obesity and an increased risk of heart attacks.